Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLP
2376
DELISTED
Cantaloupe
CTLP
| $4.78M | ﹤0.01% |
403,035
+151,121
| +60% | +$1.77M |
|
2377
Gorman-Rupp
GRC
$2.14B
| $4.76M | ﹤0.01% |
138,353
+13,670
| +11% | +$476K |
|
2378
Liquidity Services
LQDT
$1.22B
| $4.76M | ﹤0.01% |
186,984
+4,831
| +3% | +$106K |
|
|
LTRPA
2379
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $4.75M | ﹤0.01% |
1,167,965
-986
| -0.1% | -$4.78K |
|
2380
Precigen
PGEN
$2.24B
| $4.73M | ﹤0.01% |
725,930
+142,587
| +24% | +$996K |
|
2381
Golar LNG
GLNG
$5B
| $4.73M | ﹤0.01% |
357,205
+39,373
| +12% | +$469K |
|
|
CCXI
2382
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.73M | ﹤0.01% |
353,138
-21,530
| -6% | -$530K |
|
2383
Costamare
CMRE
$1.88B
| $4.69M | ﹤0.01% |
397,254
-225,854
| -36% | -$2.43M |
|
2384
Latham Group
SWIM
$629M
| $4.69M | ﹤0.01% |
+146,598
| New | +$4.28M |
|
|
ZY
2385
DELISTED
Zymergen Inc. Common Stock
ZY
| $4.65M | ﹤0.01% |
+116,290
| New | +$4.59M |
|
2386
Spruce Power Holding Corp
SPRU
$35.8M
| $4.64M | ﹤0.01% |
69,608
+14,668
| +27% | +$864K |
|
|
RFP
2387
DELISTED
Resolute Forest Products Inc.
RFP
| $4.64M | ﹤0.01% |
380,176
+860
| +0.2% | +$12K |
|
2388
Arcos Dorados Holdings
ARCO
$1.72B
| $4.63M | ﹤0.01% |
786,975
+1,687
| +0.2% | +$9.91K |
|
2389
Syndax Pharmaceuticals
SNDX
$1.69B
| $4.63M | ﹤0.01% |
269,631
+38,698
| +17% | +$709K |
|
|
WTRE
2390
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $4.61M | ﹤0.01% |
131,855
+3,499
| +3% | +$122K |
|
|
ALTA
2391
DELISTED
Altabancorp
ALTA
| $4.61M | ﹤0.01% |
106,464
+5,018
| +5% | +$219K |
|
2392
Stoke Therapeutics
STOK
$1.8B
| $4.6M | ﹤0.01% |
136,622
+14,262
| +12% | +$504K |
|
|
CPRX
2393
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.6M | ﹤0.01% |
799,239
-170,468
| -18% | -$880K |
|
2394
Pulmonx
LUNG
$68.8M
| $4.6M | ﹤0.01% |
104,156
+31,424
| +43% | +$1.37M |
|
|
TRST
2395
Trustco Bank Corp NY
TRST
$970M
| $4.58M | ﹤0.01% |
133,219
+2,305
| +2% | +$85.3K |
|
|
HTBK
2396
DELISTED
Heritage Commerce
HTBK
| $4.58M | ﹤0.01% |
411,063
+9,492
| +2% | +$113K |
|
2397
Futu Holdings
FUTU
$14.7B
| $4.57M | ﹤0.01% |
+25,538
| New | +$3.71M |
|
|
NTST
2398
NETSTREIT Corp
NTST
$2.09B
| $4.57M | ﹤0.01% |
198,074
+83,937
| +74% | +$1.83M |
|
2399
Ecopetrol
EC
$34.5B
| $4.56M | ﹤0.01% |
312,017
+14,872
| +5% | +$190K |
|
|
PENG
2400
Penguin Solutions Inc
PENG
$2.7B
| $4.54M | ﹤0.01% |
190,390
-2,128
| -1% | -$51.3K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.